1. Home
  2. CNXN vs AGIO Comparison

CNXN vs AGIO Comparison

Compare CNXN & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CNXN

PC Connection Inc.

HOLD

Current Price

$58.55

Market Cap

1.6B

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$28.39

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNXN
AGIO
Founded
1982
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
1998
2013

Fundamental Metrics

Financial Performance
Metric
CNXN
AGIO
Price
$58.55
$28.39
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$36.25
AVG Volume (30 Days)
80.6K
1.6M
Earning Date
02-04-2026
02-12-2026
Dividend Yield
1.03%
N/A
EPS Growth
N/A
N/A
EPS
3.24
N/A
Revenue
$2,878,704,000.00
$44,791,000.00
Revenue This Year
$5.85
$28.75
Revenue Next Year
$4.52
$139.45
P/E Ratio
$18.02
N/A
Revenue Growth
3.19
36.26
52 Week Low
$54.97
$22.24
52 Week High
$74.84
$46.00

Technical Indicators

Market Signals
Indicator
CNXN
AGIO
Relative Strength Index (RSI) 46.78 50.27
Support Level $56.53 $26.54
Resistance Level $58.95 $29.44
Average True Range (ATR) 1.25 1.07
MACD -0.11 0.58
Stochastic Oscillator 44.93 71.60

Price Performance

Historical Comparison
CNXN
AGIO

About CNXN PC Connection Inc.

PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: